✦ LIBER ✦

55 Phase II study of amrubicin (SM-5887), a novel 9-amino-anthracycline, in previously untreated patients with extensive-stage small-cell lung cancer (ES-SCLC): A trial of the west Japan lung cancer group

✍ Scribed by Yokota, S.; Negoro, S.; Yana, T.; Takada, Y.; Fukuoka, M.

Book ID: 123101167
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 159 KB
Volume: 18
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(97)89334-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of paclitaxel in previo

A phase II trial of paclitaxel in previously untreated patients with extensive-stage small cell lung cancer (SCLC)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 61 KB

A phase II trial of intravenous vinorelb

A phase II trial of intravenous vinorelbine in previously untreated patients with extensive small cell lung cancer, a southwest oncology group study

✍ Celestia S. Higano; John J. Crowley; Robert V. Veith; Robert B. Livingston 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 28 KB

Phase II study of docetaxel (taxotere) i

Phase II study of docetaxel (taxotere) in patients with previously untreated extensive small cell lung cancer. A trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG)

📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 133 KB

A phase II study of paclitaxel and granu

A phase II study of paclitaxel and granulocyte colony-stimulating factor in previously untreated patients with extensive-stage small cell lung cancer: A study of the North Central Cancer Treatment Group

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Phase II trial of topotecan and paclitax

Phase II trial of topotecan and paclitaxel (TP) with G-CSF support alternating with etoposide and cisplatin (EC) in previously untreated extensive stage small cell lung cancer (ED-SCLC): A North Central Cancer Treatment Group study

✍ Jett, J.R; Hatfield, A; Bauman, M; Hillman, S; Soori, G; Veeder, M; Morton, R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Alternating chemotherapy with etoposide

Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma : A Phase II trial of the North Central Cancer Treatment Group

✍ James R. Jett; Alan K. Hatfield; Shauna Hillman; Michael D. Bauman; James A. Mai 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 3 views

## Abstract ## BACKGROUND The objective of this study was to test the response rate and toxicity of alternating chemotherapy in previously untreated patients with extensive‐stage small cell lung carcinoma (SCLC). ## METHODS Patients with histologically proven, extensive‐stage SCLC, with a perfor